曼恩凯德生物医疗(MNKD)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

MNKD 曼恩凯德生物医疗

休市中 11-22 16:00:00 EST

6.84

-0.06

-0.87%

盘后6.88

+0.04+0.58%

19:58 EST

最高7.01	最低6.82	成交量302.66万
今开6.94	昨收6.90	日振幅2.68%
总市值18.86亿	流通市值18.45亿	总股本2.76亿
成交额2,085万	换手率1.12%	流通股本2.70亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"MNKD","market":"US","secType":"STK","nameCN":"曼恩凯德生物医疗","latestPrice":6.84,"timestamp":1732309200000,"preClose":6.9,"halted":0,"volume":3026588,"hourTrading":{"tag":"盘后","latestPrice":6.8797,"preClose":6.84,"latestTime":"19:58 EST","volume":332686,"amount":2275905.0326,"timestamp":1732323495749},"delay":0,"floatShares":269679972,"shares":275777693,"eps":0.079282,"marketStatus":"休市中","marketStatusCode":7,"change":-0.06,"latestTime":"11-22 16:00:00 EST","open":6.94,"high":7.005,"low":6.82,"amount":20850502.196562,"amplitude":0.026812,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.079282,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1732525200000},"adr":0,"listingDate":1090987200000,"adjPreClose":6.9,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":6.98,"preClose":6.9,"latestTime":"09:28 EST","volume":2408,"amount":16758.046172,"timestamp":1732285700441},"postHourTrading":{"tag":"盘后","latestPrice":6.8797,"preClose":6.84,"latestTime":"19:58 EST","volume":332686,"amount":2275905.0326,"timestamp":1732323495749},"volumeRatio":1.021519911227648,"impliedVol":0.2092,"impliedVolPercentile":0.0873},"requestUrl":"/m/hq/s/MNKD/tweets","defaultTab":"tweets","newsList":[{"id":"2484104905","title":"曼恩凯德生物医疗2024财年第三财季实现净利润11.55百万美元，同比增加571.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484104905","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484104905?lang=zh_cn&edition=full","pubTime":"2024-11-17 00:03","pubTimestamp":1731773000,"startTime":"0","endTime":"0","summary":"11月17日，曼恩凯德生物医疗公布财报，公告显示公司2024财年第三财季净利润为11.55百万美元，同比增加571.51%；其中营业收入为70.08百万美元，同比增加36.74%，每股基本收益为0.04美元。从资产负债表来看，曼恩凯德生物医疗总负债6.74亿美元，其中短期债务13.07百万美元，资产负债比为0.69，流动比率为0.05。机构评级：截至2024年11月17日，当前有5家机构对曼恩凯德生物医疗目标价做出预测，其中目标均价为9.40美元，其中最低目标价为7.00美元，最高目标价为12.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241117000435a23e0722&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241117000435a23e0722&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MNKD"],"gpt_icon":0},{"id":"2483384721","title":"曼恩凯德生物医疗盘中异动 临近午盘快速上涨5.32%报7.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483384721","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483384721?lang=zh_cn&edition=full","pubTime":"2024-11-15 00:55","pubTimestamp":1731603324,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日00时55分，曼恩凯德生物医疗股票出现异动，股价快速拉升5.32%。截至发稿，该股报7.33美元/股，成交量136.357万股，换手率0.49%，振幅5.89%。机构评级方面，在所有5家参与评级的机构中，80%的券商给予买入建议，20%的券商给予持有建议，无券商给予卖出建议。曼恩凯德生物医疗股票所在的生物技术行业中，整体跌幅为0.64%。曼恩凯德生物医疗公司简介：MannKind Corp是一家生物制药公司。该产品由小型便携式吸入器提供的人胰岛素干粉制剂组成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115005525971a69c9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115005525971a69c9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4584","MNKD"],"gpt_icon":0},{"id":"2481101760","title":"曼恩凯德生物医疗盘中异动 早盘股价大跌9.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481101760","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481101760?lang=zh_cn&edition=full","pubTime":"2024-11-08 22:32","pubTimestamp":1731076368,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日22时32分，曼恩凯德生物医疗股票出现波动，股价急速下挫9.42%。截至发稿，该股报6.69美元/股，成交量50.0499万股，换手率0.18%，振幅5.68%。机构评级方面，在所有4家参与评级的机构中，75%的券商给予买入建议，25%的券商给予持有建议，无券商给予卖出建议。曼恩凯德生物医疗股票所在的生物技术行业中，整体涨幅为0.42%。曼恩凯德生物医疗公司简介：MannKind Corp是一家生物制药公司。该产品由小型便携式吸入器提供的人胰岛素干粉制剂组成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110822324895bdef38&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110822324895bdef38&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MNKD","BK4584","BK4139"],"gpt_icon":0},{"id":"2481361398","title":"MannKind Corp   预计每股收益3美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2481361398","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481361398?lang=zh_cn&edition=full","pubTime":"2024-11-06 11:43","pubTimestamp":1730864638,"startTime":"0","endTime":"0","summary":"   * MannKind公司   预计在11月7日公布截至2024年9月30日的财报时，季度收入将出现增长。* 根据LSEG的数据，3位分析师的平均预期显示，这家总部位于康涅狄格州丹伯里的公司的营收预计将从去年同期的5125万美元增长45.4%，达到7450万美元。* LSEG分析师对MannKind公司的平均预期为每股收益3美分。* 华尔街对 MannKind 公司 12 个月目标价的中位数为 7.50 美元，高于其最新收盘价 7.26 美元。11月6日 - 以往季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"MannKind Corp   预计每股收益3美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MNKD"],"gpt_icon":0},{"id":"2478148734","title":"曼恩凯德生物医疗盘中异动 快速拉升5.20%报6.88美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478148734","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478148734?lang=zh_cn&edition=full","pubTime":"2024-10-28 22:44","pubTimestamp":1730126676,"startTime":"0","endTime":"0","summary":"北京时间2024年10月28日22时44分，曼恩凯德生物医疗股票出现异动，股价急速拉升5.20%。截至发稿，该股报6.88美元/股，成交量50.734万股，换手率0.18%，振幅4.20%。机构评级方面，在所有4家参与评级的机构中，75%的券商给予买入建议，25%的券商给予持有建议，无券商给予卖出建议。曼恩凯德生物医疗股票所在的生物技术行业中，整体涨幅为0.58%。曼恩凯德生物医疗公司简介：MannKind Corp是一家生物制药公司。该产品由小型便携式吸入器提供的人胰岛素干粉制剂组成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028224437ab7becba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028224437ab7becba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4584","BK4139","MNKD"],"gpt_icon":0},{"id":"2472673611","title":"曼恩凯德生物医疗盘中异动 快速拉升5.17%报6.62美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2472673611","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472673611?lang=zh_cn&edition=full","pubTime":"2024-10-03 22:07","pubTimestamp":1727964437,"startTime":"0","endTime":"0","summary":"北京时间2024年10月03日22时07分，曼恩凯德生物医疗股票出现波动，股价大幅上涨5.17%。截至发稿，该股报6.62美元/股，成交量69.1327万股，换手率0.25%，振幅5.41%。机构评级方面，在所有4家参与评级的机构中，75%的券商给予买入建议，25%的券商给予持有建议，无券商给予卖出建议。曼恩凯德生物医疗股票所在的生物技术行业中，整体跌幅为0.63%。曼恩凯德生物医疗公司简介：MannKind Corp是一家生物制药公司。该产品由小型便携式吸入器提供的人胰岛素干粉制剂组成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241003220717ab6799a8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241003220717ab6799a8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4584","MNKD","BK4139"],"gpt_icon":0},{"id":"2460703209","title":"曼恩凯德生物医疗盘中异动 早盘急速拉升5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460703209","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460703209?lang=zh_cn&edition=full","pubTime":"2024-08-19 21:57","pubTimestamp":1724075820,"startTime":"0","endTime":"0","summary":"北京时间2024年08月19日21时57分，曼恩凯德生物医疗股票出现波动，股价快速上涨5.06%。截至发稿，该股报5.40美元/股，成交量44.2137万股，换手率0.16%，振幅4.14%。机构评级方面，在所有4家参与评级的机构中，75%的券商给予买入建议，25%的券商给予持有建议，无券商给予卖出建议。曼恩凯德生物医疗股票所在的生物技术行业中，整体涨幅为1.00%。曼恩凯德生物医疗公司简介：MannKind Corp是一家生物制药公司。该产品由小型便携式吸入器提供的人胰岛素干粉制剂组成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408192157019719924e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408192157019719924e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MNKD","BK4584","BK4139"],"gpt_icon":0},{"id":"2460492652","title":"曼恩凯德生物医疗2024财年第二财季实现净利润-2.01百万美元，同比增加61.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460492652","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460492652?lang=zh_cn&edition=full","pubTime":"2024-08-17 00:00","pubTimestamp":1723824030,"startTime":"0","endTime":"0","summary":"8月17日，曼恩凯德生物医疗公布财报，公告显示公司2024财年第二财季净利润为-2.01百万美元，同比增加61.86%；其中营业收入为72.39百万美元，同比增加48.92%，每股基本收益为-0.01美元。从资产负债表来看，曼恩凯德生物医疗总负债6.70亿美元，其中短期债务13.10百万美元，资产负债比为0.67，流动比率为0.05。机构评级：截至2024年8月17日，当前有5家机构对曼恩凯德生物医疗目标价做出预测，其中目标均价为7.30美元，其中最低目标价为5.00美元，最高目标价为10.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408170004429f31afb2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408170004429f31afb2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MNKD"],"gpt_icon":0},{"id":"2457770338","title":"MannKind Corp   预计每股收益1美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2457770338","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457770338?lang=zh_cn&edition=full","pubTime":"2024-08-05 23:55","pubTimestamp":1722873323,"startTime":"0","endTime":"0","summary":"   * MannKind公司   将于8月7日公布截至2024年6月30日的财报，预计该公司的季度收入将有所增长。* 根据LSEG的数据，4位分析师的平均预期显示，这家总部位于康涅狄格州丹伯里的公司的营收预计将从去年同期的4861万美元增长33.3%，达到6481.3万美元。* LSEG 分析师对 MannKind 公司的平均预期为每股收益 1 美分。* 华尔街对 MannKind 公司 12 个月目标价的中位数为 6.50 美元，高于其上次收盘价 5.34 美元。8月5日 - 以前季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"MannKind Corp   预计每股收益1美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MNKD"],"gpt_icon":0},{"id":"2457754817","title":"曼恩凯德生物医疗盘中异动 股价大跌6.37%报5.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457754817","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457754817?lang=zh_cn&edition=full","pubTime":"2024-08-05 21:35","pubTimestamp":1722864958,"startTime":"0","endTime":"0","summary":"北京时间2024年08月05日21时35分，曼恩凯德生物医疗股票出现波动，股价急速跳水6.37%。截至发稿，该股报5.00美元/股，成交量18.8727万股，换手率0.07%，振幅1.50%。最近的财报数据显示，该股实现营业收入66.26百万美元，净利润10.63百万美元，每股收益0.04美元，毛利47.67百万美元，市盈率125.00倍。曼恩凯德生物医疗股票所在的生物技术行业中，整体跌幅为1.75%。曼恩凯德生物医疗公司简介：MannKind Corp是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408052135589f107166&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408052135589f107166&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4584","MNKD"],"gpt_icon":0},{"id":"2450836360","title":"曼恩凯德生物医疗盘中异动 急速上涨5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450836360","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450836360?lang=zh_cn&edition=full","pubTime":"2024-07-09 00:49","pubTimestamp":1720457342,"startTime":"0","endTime":"0","summary":"北京时间2024年07月09日00时49分，曼恩凯德生物医疗股票出现波动，股价急速上涨5.07%。截至发稿，该股报5.39美元/股，成交量91.9796万股，换手率0.34%，振幅4.48%。机构评级方面，在所有5家参与评级的机构中，80%的券商给予买入建议，20%的券商给予持有建议，无券商给予卖出建议。曼恩凯德生物医疗股票所在的生物技术行业中，整体涨幅为0.90%。曼恩凯德生物医疗公司简介：MannKind Corp是一家生物制药公司。该产品由小型便携式吸入器提供的人胰岛素干粉制剂组成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240709004902af911af4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240709004902af911af4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4584","MNKD","BK4139"],"gpt_icon":0},{"id":"2446529004","title":"曼恩凯德生物医疗盘中异动 快速拉升5.19%报5.38美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446529004","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446529004?lang=zh_cn&edition=full","pubTime":"2024-06-25 00:43","pubTimestamp":1719247401,"startTime":"0","endTime":"0","summary":"北京时间2024年06月25日00时43分，曼恩凯德生物医疗股票出现波动，股价大幅上涨5.19%。截至发稿，该股报5.38美元/股，成交量186.988万股，换手率0.69%，振幅5.17%。曼恩凯德生物医疗股票所在的生物技术行业中，整体涨幅为1.89%。曼恩凯德生物医疗公司简介：MannKind Corp是一家生物制药公司。该产品由小型便携式吸入器提供的人胰岛素干粉制剂组成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240625004321968164b8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240625004321968164b8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4584","MNKD","BK4139"],"gpt_icon":0},{"id":"2443670005","title":"曼恩凯德生物医疗盘中异动 股价大跌5.06%报4.79美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2443670005","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2443670005?lang=zh_cn&edition=full","pubTime":"2024-06-15 00:33","pubTimestamp":1718382828,"startTime":"0","endTime":"0","summary":"北京时间2024年06月15日00时33分，曼恩凯德生物医疗股票出现波动，股价快速下跌5.06%。截至发稿，该股报4.79美元/股，成交量90.532万股，换手率0.33%，振幅4.17%。曼恩凯德生物医疗股票所在的生物技术行业中，整体跌幅为0.01%。曼恩凯德生物医疗公司简介：MannKind Corp是一家生物制药公司。消息层面，截至00时33分，《Rodman & Renshaw首予曼恩凯德生物医疗买入评级，目标价8美元》资讯为影响曼恩凯德生物医疗的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240615003349968145a9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240615003349968145a9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MNKD","BK4584"],"gpt_icon":0},{"id":"2443639506","title":"曼恩凯德生物医疗盘中异动 下午盘大幅上涨5.18%报4.98美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2443639506","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2443639506?lang=zh_cn&edition=full","pubTime":"2024-06-14 01:11","pubTimestamp":1718298669,"startTime":"0","endTime":"0","summary":"北京时间2024年06月14日01时11分，曼恩凯德生物医疗股票出现异动，股价快速拉升5.18%。截至发稿，该股报4.98美元/股，成交量105.602万股，换手率0.39%，振幅5.07%。曼恩凯德生物医疗股票所在的生物技术行业中，整体跌幅为0.07%。曼恩凯德生物医疗公司简介：MannKind Corp是一家生物制药公司。消息层面，截至01时11分，《Rodman & Renshaw首予曼恩凯德生物医疗买入评级，目标价8美元》资讯为影响曼恩凯德生物医疗的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240614011109968140f6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240614011109968140f6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4584","MNKD"],"gpt_icon":0},{"id":"2442847657","title":"曼恩凯德生物医疗盘中异动 早盘股价大跌5.14%报4.43美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2442847657","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2442847657?lang=zh_cn&edition=full","pubTime":"2024-06-10 21:48","pubTimestamp":1718027313,"startTime":"0","endTime":"0","summary":"北京时间2024年06月10日21时48分，曼恩凯德生物医疗股票出现波动，股价快速下跌5.14%。截至发稿，该股报4.43美元/股，成交量35.9463万股，换手率0.13%，振幅3.21%。最近的财报数据显示，该股实现营业收入66.26百万美元，净利润10.63百万美元，每股收益0.04美元，毛利47.67百万美元，市盈率111.38倍。曼恩凯德生物医疗股票所在的生物技术行业中，整体跌幅为0.48%。曼恩凯德生物医疗公司简介：MannKind Corp是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240610214834aef42baf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240610214834aef42baf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4584","BK4139","MNKD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.mannkindcorp.com","stockEarnings":[{"period":"1week","weight":0.0059},{"period":"1month","weight":0.0539},{"period":"3month","weight":0.2737},{"period":"6month","weight":0.431},{"period":"1year","weight":0.874},{"period":"ytd","weight":0.8791}],"compareEarnings":[{"period":"1week","weight":0.0167},{"period":"1month","weight":0.0303},{"period":"3month","weight":0.0594},{"period":"6month","weight":0.1248},{"period":"1year","weight":0.3088},{"period":"ytd","weight":0.2529}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Mannkind Corporation于1991年2月14日在美国特拉华州注册成立。Mannkind Corporation是一家生物制药公司，侧重于诸如糖尿病和癌症之类疗法和药品的开发、研制和推广。该公司的主导候选产品——AFREZZA吸入粉末，是一种超速效胰岛素，处于后期临床研究阶段，用于成人1型或2型糖尿病高血糖的控制治疗。AFREZZA是由该公司的专有技术圈颗粒加载到胰岛素分子里。这些加载的粒子雾化吸入后，会深入到使用AFREZZA吸入器的肺部。糖尿病是一个重大的健康问题。","yearOnYearQuotes":[{"month":1,"riseRate":0.7,"avgChangeRate":0.045334},{"month":2,"riseRate":0.4,"avgChangeRate":-0.004536},{"month":3,"riseRate":0.45,"avgChangeRate":-0.008047},{"month":4,"riseRate":0.4,"avgChangeRate":-0.028112},{"month":5,"riseRate":0.55,"avgChangeRate":0.120551},{"month":6,"riseRate":0.55,"avgChangeRate":0.062891},{"month":7,"riseRate":0.3,"avgChangeRate":-0.060302},{"month":8,"riseRate":0.428571,"avgChangeRate":0.006818},{"month":9,"riseRate":0.666667,"avgChangeRate":0.074573},{"month":10,"riseRate":0.47619,"avgChangeRate":-0.038748},{"month":11,"riseRate":0.428571,"avgChangeRate":0.023175},{"month":12,"riseRate":0.55,"avgChangeRate":-0.01539}],"exchange":"NASDAQ","name":"曼恩凯德生物医疗","nameEN":"MannKind"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"曼恩凯德生物医疗(MNKD)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供曼恩凯德生物医疗(MNKD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"曼恩凯德生物医疗,MNKD,曼恩凯德生物医疗股票,曼恩凯德生物医疗股票老虎,曼恩凯德生物医疗股票老虎国际,曼恩凯德生物医疗行情,曼恩凯德生物医疗股票行情,曼恩凯德生物医疗股价,曼恩凯德生物医疗股市,曼恩凯德生物医疗股票价格,曼恩凯德生物医疗股票交易,曼恩凯德生物医疗股票购买,曼恩凯德生物医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"曼恩凯德生物医疗(MNKD)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供曼恩凯德生物医疗(MNKD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}